DE69940903D1 - Diagnostische methoden basierend auf katalytischen nukleinsäuren - Google Patents

Diagnostische methoden basierend auf katalytischen nukleinsäuren

Info

Publication number
DE69940903D1
DE69940903D1 DE69940903T DE69940903T DE69940903D1 DE 69940903 D1 DE69940903 D1 DE 69940903D1 DE 69940903 T DE69940903 T DE 69940903T DE 69940903 T DE69940903 T DE 69940903T DE 69940903 D1 DE69940903 D1 DE 69940903D1
Authority
DE
Germany
Prior art keywords
nucleic acid
catalytic nucleic
nucleic acids
methods based
diagnostic methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69940903T
Other languages
English (en)
Inventor
Alison V Todd
Caroline J Fuery
Murray J Cairns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Research Pty Ltd
Original Assignee
Johnson and Johnson Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson Research Pty Ltd filed Critical Johnson and Johnson Research Pty Ltd
Application granted granted Critical
Publication of DE69940903D1 publication Critical patent/DE69940903D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69940903T 1998-03-27 1999-03-16 Diagnostische methoden basierend auf katalytischen nukleinsäuren Expired - Fee Related DE69940903D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7965198P 1998-03-27 1998-03-27
PCT/IB1999/000848 WO1999050452A1 (en) 1998-03-27 1999-03-16 Catalytic nucleic acid-based diagnostic methods

Publications (1)

Publication Number Publication Date
DE69940903D1 true DE69940903D1 (de) 2009-07-02

Family

ID=22151922

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69940903T Expired - Fee Related DE69940903D1 (de) 1998-03-27 1999-03-16 Diagnostische methoden basierend auf katalytischen nukleinsäuren

Country Status (10)

Country Link
US (1) US6361941B1 (de)
EP (1) EP1025266B1 (de)
AT (1) ATE431852T1 (de)
AU (2) AU763135B2 (de)
CA (1) CA2312288A1 (de)
DE (1) DE69940903D1 (de)
IL (1) IL136443A (de)
TW (1) TWI227737B (de)
WO (1) WO1999050452A1 (de)
ZA (1) ZA992374B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7141665B1 (en) * 1998-04-29 2006-11-28 The Scripps Research Institute Enzymatic DNA molecules
AU5298699A (en) * 1998-08-13 2000-03-06 Johnson & Johnson Research Pty. Limited Dnazymes and methods for treating hpv-related disorders
AU5298499A (en) * 1998-08-13 2000-03-06 Johnson & Johnson Research Pty. Limited Dnazymes and methods for treating restenosis
AUPP810399A0 (en) * 1999-01-11 1999-02-04 Unisearch Limited Catalytic molecules
AUPQ201499A0 (en) * 1999-08-04 1999-08-26 Unisearch Limited Treatment of inflammatory and malignant diseases
US20040009510A1 (en) * 2000-03-06 2004-01-15 Scott Seiwert Allosteric nucleic acid sensor molecules
AU2002305174A1 (en) * 2001-04-13 2002-10-28 Johns Hopkins University School Of Medicine Methods and compositions for identifying disease genes using nonsense-mediated decay inhibition
US20050288242A1 (en) * 2001-05-18 2005-12-29 Sirna Therapeutics, Inc. RNA interference mediated inhibition of RAS gene expression using short interfering nucleic acid (siNA)
WO2002097114A2 (en) * 2001-05-29 2002-12-05 Sirna Therapeutics, Inc. Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv
AU2002367785A1 (en) * 2001-11-05 2003-11-03 Sirna Therapeutics, Inc Allosteric nucleic acid sensor molecules
DE10346487A1 (de) * 2003-10-02 2005-05-12 Transmit Technologietransfer Verfahren zur Herstellung eines Zell- und/oder Gewebe- und/oder Krankheitsphasen-spezifischen Arzneimittels
WO2005078848A2 (en) * 2004-02-11 2005-08-25 University Of Tennessee Research Foundation Inhibition of tumor growth and invasion by anti-matrix metalloproteinase dnazymes
US20050250134A1 (en) * 2004-03-02 2005-11-10 Dawei Sheng Fluorescent energy transfer labeled nucleic acid substrates and methods of use thereof
DK2385141T3 (da) 2005-10-07 2013-10-28 Speedx Pty Ltd Flerkomponentnukleinsyreenzymer og fremgangsmåder til anvendelse heraf
ZA200901742B (en) 2006-10-06 2010-06-30 Johnson & Johnson Res Pty Ltd Moleculor switches and methods for their use
US9938641B2 (en) * 2006-12-18 2018-04-10 Fluidigm Corporation Selection of aptamers based on geometry
EP2142673B1 (de) 2007-04-05 2013-05-22 Johnson & Johnson Research Pty Limited Nukleinsäureenzyme und komplexe sowie verfahren zur verwendung davon
EP2162551B1 (de) * 2007-07-03 2017-08-23 Genaphora LTD. Chmäre primer für verbesserte nukleinsäureamplifkationsreaktionen
EP2776586B1 (de) * 2011-11-11 2018-03-07 Millennium Pharmaceuticals, Inc. Biomarker der reaktion auf proteasomenhemmer
KR20230133859A (ko) 2020-12-28 2023-09-19 1이 테라퓨틱스 엘티디. p21 mRNA 표적화 DNA자임
WO2022144882A2 (en) * 2020-12-28 2022-07-07 1E Therapeutics, Ltd. P21 mrna target areas for silencing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989012697A1 (en) * 1988-06-22 1989-12-28 The Board Of Regents Of The University Of Washingt Method for detecting abnormal genes
EP0525882B1 (de) * 1991-08-02 2004-01-14 bioMerieux B.V. Quantifikation von Nukleinsäuren
US6025127A (en) * 1994-01-14 2000-02-15 The Johns Hopkins University School Of Medicine Nucleic acid mutation detection in histologic tissue
US5807718A (en) * 1994-12-02 1998-09-15 The Scripps Research Institute Enzymatic DNA molecules
EP0948645A4 (de) * 1996-09-18 2002-11-05 Gen Hospital Corp Erkennungsverfahren durch restriktionsfragmentlängenpolymorphismen (rflp)
US6600030B2 (en) * 1997-08-14 2003-07-29 The United States Of America As Represented By The Department Of Health And Human Services Delayed progression to aids by a missense allele of the CCR2 gene

Also Published As

Publication number Publication date
WO1999050452A1 (en) 1999-10-07
AU763135B2 (en) 2003-07-17
EP1025266A4 (de) 2002-10-29
CA2312288A1 (en) 1999-10-07
IL136443A0 (en) 2001-06-14
AU3530399A (en) 1999-10-18
ATE431852T1 (de) 2009-06-15
US6361941B1 (en) 2002-03-26
AU2003252934A1 (en) 2003-11-06
TWI227737B (en) 2005-02-11
EP1025266B1 (de) 2009-05-20
IL136443A (en) 2005-06-19
ZA992374B (en) 2000-10-11
EP1025266A1 (de) 2000-08-09

Similar Documents

Publication Publication Date Title
DE69940903D1 (de) Diagnostische methoden basierend auf katalytischen nukleinsäuren
ATE414169T1 (de) Methoden zur detektion von nukleinsäuren unter verwendung von zymogenen und dazugehörige kits
ES2176233T3 (es) Deteccion diagnostica amplificada con ribozimas.
EE200100340A (et) Meetod signaali võimendamiseks, meetod kogu sihtnukleiinhappemolekuli või selle osa sekveneerimiseks, reaktiivikomplekt ja meetod sihtnukleiinhappemolekuli kaardistamiseks
DE69940265D1 (de) Alzheimersche krankheit sekretase
DE69607830T2 (de) Verfahren zur isothermer amplifikation von nukleinsäure molekülen
AU9743398A (en) Detection and identification of human papillomavirus by pcr and type-specific r everse hybridization
DE60119170D1 (de) Nachweismethode mittels verstärkter silberfärbung
DE60035691D1 (de) Verfahren zur Erkennung von Einzel-Nukleotid-Polymorphismen
US8188257B1 (en) Direct quantification of ribosome inactivating protein
BR0014518A (pt) Método e ácidos nucléicos para a detecção de microorganismos pertinentes à fermentação
ATE255595T1 (de) Nephrin gen und protein
Qiao et al. Sensitive analysis of single nucleotide variation by Cas13d orthologs, EsCas13d and RspCas13d
NO971086D0 (no) Forsterkning og detektering av målnukleinsyrer ved bruk av et efterforsterkningsinkuberingstrinn
Nichols et al. Single molecule assays of β-galactosidase from two wild-type strains of E. coli: effects of protease inhibitors on microheterogeneity and different relative activities with differing substrates
ES540654A0 (es) Procedimiento para la obtencion de la nueva enzima 1-meti- lhidantoinasa.
Xu et al. A universal sensing platform based on the repair ligation-mediated light-producing DNA machine
US20210348219A1 (en) Target nucleic acid detection method based on proximity proteolysis reaction
EP4073262A1 (de) Verfahren und kit zur detektion von polynukleotid
FR2816955B1 (fr) Substrat, substrat combines, milieu de culture et procede d'identification de l'espece listeria monocytogenes
DE69610933D1 (de) Verfahren und reagenzien zur typisierung von hla-genen der klasse i
ATE513061T1 (de) Diagnostisches verfahren und kit zur bestimmung des kell-blutgruppengenotyps
ATE259883T1 (de) Diagnostische methode basierend auf der function eines proteins das in einer zellfreien umgebung produziert wird, ausgehend von einer probe von nukleinsäuren
JP2023549287A (ja) 核酸検出及び疾患診断のための、質量分析に基づく方法及びキット
OA20750A (en) Method and kit for detection of polynucleotide.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee